Skip to main content
. 2010 Jan 28;31(4):654–659. doi: 10.1093/carcin/bgq017

Table III.

Logistic regression examining the association between bleomycin sensitivity and breast cancer risk

MSA categories (b/c) Cases–controls ORa (95% CI) Cases–controls ORa (95% CI)
All subjects
    Low (≤0.64) 51/85 1.00
    High (>0.65) 113/80 2.8 (1.7–4.5)
    Hyposensitive (≤0.48) 21/43 1.00
    Sensitive (0.49–0.86) 73/80 2.0 (1.1–3.9)
    Hypersensitive (≥0.87) 70/42 3.8 (1.9–7.5)
    P trend <0.01
White women Black women
    Low (≤0.64) 41/65 1.00 6/17 1.00
    High (>0.65) 84/61 2.4 (1.4–4.2) 23/14 6.9 (1.7–28.1)
    Hyposensitive (≤0.48) 17/36 1.00 2/6 1.00
    Sensitive (0.49–0.86) 54/58 2.0 (1.0–4.2) 15/17 3.8 (0.6–27.0)
    Hypersensitive (≥0.87) 54/32 3.8 (1.7–8.1) 12/8 6.9 (0.9–54.3)
    P trend <0.01 0.07
Premenopausal women Postmenopausal women
    Low (≤0.64) 25/47 1.00 22/38 1.00
    High (>0.65) 43/27 3.3 (1.6–6.9) 65/51 2.5 (1.3–5.0)
    Hyposensitive (≤0.48) 10/23 1.00 11/20 1.00
    Sensitive (0.49–0.86) 33/35 2.7 (1.1–7.1) 35/44 1.8 (0.7–4.7)
    Hypersensitive (≥0.87) 25/16 4.7 (1.7–13.3) 41/25 3.7 (1.4–9.5)
    P trend <0.01 <0.01
Postmenopausal women only Postmenopausal women only
Ever user of HRT Never user of HRT
    Low (≤0.64) 11/26 1.00 9/12 1.00
    High (>0.65) 31/29 2.6 (1.0–6.5) 31/22 1.9 (0.6–6.0)
    Hyposensitive (≤0.48) 5/14 1.00 5/6 1.00
    Sensitive (0.49–0.86) 19/26 2.7 (0.7–10.0) 15/18 1.2 (0.3–5.1)
    Hypersensitive (≥0.87) 18/15 4.2 (1.1–16.0) 20/10 2.2 (0.5–10.5)
    P trend 0.03 0.23
Ever smokers Never smokers
    Low (≤0.64) 18/38 1.00 30/47 1.00
    High (>0.65) 40/32 3.5 (1.5–8.0) 71/46 2.4 (1.3–4.6)
    Hyposensitive (≤0.48) 8/19 1.00 12/24 1.00
    Sensitive (0.49–0.86) 19/33 1.6 (0.6–4.7) 51/46 2.3 (1.0–5.4)
    Hypersensitive (≥0.87) 31/18 6.4 (2.0–20.2) 38/23 2.7 (1.1–6.8)
    P trend <0.01 0.04

b/c, breaks per cell.

a

Adjusted for age at interview, race (when appropriate), physical activity at teens, environmental tobacco smoking at work and menopausal status (when appropriate).